Simulations Plus Inc
NASDAQ:SLP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Iris Clothings Ltd
NSE:IRISDOREME
|
IN |
Simulations Plus Inc
Cash from Operating Activities
Simulations Plus Inc
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Simulations Plus Inc
NASDAQ:SLP
|
Cash from Operating Activities
$24.4m
|
CAGR 3-Years
4%
|
CAGR 5-Years
12%
|
CAGR 10-Years
15%
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Cash from Operating Activities
$1.4B
|
CAGR 3-Years
22%
|
CAGR 5-Years
21%
|
CAGR 10-Years
33%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Cash from Operating Activities
$117m
|
CAGR 3-Years
116%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Cash from Operating Activities
$273.3m
|
CAGR 3-Years
29%
|
CAGR 5-Years
60%
|
CAGR 10-Years
N/A
|
|
|
Omnicell Inc
NASDAQ:OMCL
|
Cash from Operating Activities
$127.3m
|
CAGR 3-Years
18%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
13%
|
|
|
W
|
Waystar Holding Corp
NASDAQ:WAY
|
Cash from Operating Activities
$309.7m
|
CAGR 3-Years
45%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Simulations Plus Inc
Glance View
Simulations Plus, Inc. provides modeling and simulation software and consulting services supporting drug discovery, development research and regulatory submissions. The company is headquartered in Lancaster, California and currently employs 135 full-time employees. The company provides prediction of properties of molecules utilizing artificial-intelligence- and machine-learning-based technology. The company also provides consulting services ranging from early drug discovery through preclinical and clinical trial development to regulatory submissions in support of product approval. The company offers 11 software products for pharmaceutical research and development, which includes GastroPlus, DDDPlus, MembranePlus, DILIsym, NAFLDsym, ADMET Predictor, MedChem Designer, MedChem Studio, PKPlus, KIWI and Monolix Suite of products through Lixoft. Its software and consulting services are provided to pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies and to academic and regulatory agencies worldwide for use in the conduct of industry-based research. Cognigen Corporation, DILIsym Services, Inc. and Lixoft are its subsidiaries.
See Also
What is Simulations Plus Inc's Cash from Operating Activities?
Cash from Operating Activities
24.4m
USD
Based on the financial report for Feb 28, 2026, Simulations Plus Inc's Cash from Operating Activities amounts to 24.4m USD.
What is Simulations Plus Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
15%
Over the last year, the Cash from Operating Activities growth was 108%. The average annual Cash from Operating Activities growth rates for Simulations Plus Inc have been 4% over the past three years , 12% over the past five years , and 15% over the past ten years .
